InvestorsHub Logo
Followers 16
Posts 1135
Boards Moderated 0
Alias Born 11/21/2017

Re: flipper44 post# 254747

Sunday, 12/08/2019 9:42:51 AM

Sunday, December 08, 2019 9:42:51 AM

Post# of 731853
I think Dave is careful to express his personal opinions separate from information that would require official disclosure from the company. I’m sure there are things that he would love to share with shareholders that he can’t due to endpoints that aren’t completed. In my communication with him, he has shared that they won’t detail progress, but will share pertinent information as endpoints are reached. We, including him, are all anxious to get to topline on the L trial. I reviewed Ikeesq’s annual meeting notes again this morning and the review reiterated to me how complex this work is to get done with cooperation from all experts and regulators in four countries. The company never said...hey, this will be easy and quick. While I lament the time that finalizing the trial has taken (mostly for patients), I don’t feel duped by the company. They said with certainty that the effort would take time and be complex, as many experts and regulators are involved.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News